100 related articles for article (PubMed ID: 18497085)
1. Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms.
Junco JA; Basalto R; Fuentes F; Bover E; Reyes O; Pimentel E; Calzada L; Castro MD; Arteaga N; López Y; Hernández H; Bringas R; Garay H; Peschke P; Bertot J; Guillén G
Adv Exp Med Biol; 2008; 617():581-7. PubMed ID: 18497085
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.
Junco JA; Peschke P; Zuna I; Ehemann V; Fuentes F; Bover E; Pimentel E; Basulto R; Reyes O; Calzada L; Castro MD; Arteaga N; López Y; Garay H; Hernández H; Bringas R; Guillén GE
Vaccine; 2007 Dec; 25(50):8460-8. PubMed ID: 18022737
[TBL] [Abstract][Full Text] [Related]
3. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
[TBL] [Abstract][Full Text] [Related]
4. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
[TBL] [Abstract][Full Text] [Related]
5. Active component of a GnRH based vaccine binds to natural GnRH receptors in Dunning R3327-G cell line and human prostate carcinoma vesicles.
Bover Fuentes E; Fuentes Aguilar F; Junco Barranco J; Zaldivar Merino I; Arteaga Moré N; Calzada Aguilera L; López Sáez Y; Pimentel Vázquez E; Basulto Baker R
J Exp Ther Oncol; 2007; 6(4):279-84. PubMed ID: 18038761
[TBL] [Abstract][Full Text] [Related]
6. Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer.
Aguilar FF; Barranco JJ; Fuentes EB; Aguilera LC; Sáez YL; Santana MD; Vázquez EP; Baker RB; Acosta OR; Pérez HG; Nieto GG
Vaccine; 2012 Oct; 30(46):6595-9. PubMed ID: 22921738
[TBL] [Abstract][Full Text] [Related]
7. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.
Talwar GP; Raina K; Gupta JC; Ray R; Wadhwa S; Ali MM
Vaccine; 2004 Sep; 22(27-28):3713-21. PubMed ID: 15315851
[TBL] [Abstract][Full Text] [Related]
8. Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.
Triozzi PL; Bolger GB; Neidhart J; Rinehart JJ; Saleh M; Allen KO; Sellers S; Waddell MJ
Prostate; 2005 Dec; 65(4):316-21. PubMed ID: 16015596
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.
Ferro VA; Khan MA; McAdam D; Colston A; Aughey E; Mullen AB; Waterston MM; Harvey MJ
Vet Immunol Immunopathol; 2004 Sep; 101(1-2):73-86. PubMed ID: 15261694
[TBL] [Abstract][Full Text] [Related]
10. Active immunization against LHRH alone or combined with LHRH-analogue treatment impedes growth of androgen-dependent prostatic carcinoma.
Ladd A; Walfield A; Tsong YY; Thau R
Am J Reprod Immunol; 1995 Sep; 34(3):200-6. PubMed ID: 8561879
[TBL] [Abstract][Full Text] [Related]
11. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
[TBL] [Abstract][Full Text] [Related]
12. Influence of Humoral Response Against GnRH, Generated by Immunization with a Therapeutic Vaccine Candidate on the Evolution of Patients with Castration-Sensitive Prostate Adenocarcinoma.
Campal-Espinosa AC; Junco-Barranco JA; Fuentes-Aguilar F; Calzada-Aguilera L; Rivacoba-Betancourt A; Rodríguez-Bueno RH; Bover-Campal AC; Bover-Fuentes EE; González L; de Quesada L; Alvarez A; Garay-Pérez HE
Technol Cancer Res Treat; 2023; 22():15330338231207318. PubMed ID: 37828833
[TBL] [Abstract][Full Text] [Related]
13. Semisynthetic anti-LHRH vaccine causing atrophy of the prostate.
Jayashankar R; Chaudhuri MK; Singh O; Alam A; Talwar GP
Prostate; 1989; 14(1):3-11. PubMed ID: 2648346
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
[TBL] [Abstract][Full Text] [Related]
15. Active immunization against gonadotropin-releasing hormone combined with androgen supplementation is a promising antifertility vaccine for males.
Ladd A; Prabhu G; Tsong YY; Probst T; Chung W; Thau RB
Am J Reprod Immunol Microbiol; 1988 Aug; 17(4):121-7. PubMed ID: 3144190
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.
Chang CH; Hsu WC; Wang CY; Jan ML; Tsai TH; Lee TW; Lynn SG; Yeh CH; Chang TJ
Anticancer Res; 2007; 27(5A):3251-8. PubMed ID: 17970068
[TBL] [Abstract][Full Text] [Related]
17. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.
Khan MA; Prevost M; Waterston MM; Harvey MJ; Ferro VA
Vaccine; 2007 Mar; 25(11):2051-63. PubMed ID: 17240004
[TBL] [Abstract][Full Text] [Related]
18. The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment.
Aguilar FF; Barranco JJ; Aguilera LC; Fuentes EB; Serradelo Leal JA; López EH; Vázquez EP; Baker RB; Acosta OR; Pérez HG; Nieto GG
J Exp Ther Oncol; 2017 Nov; 12(2):87-94. PubMed ID: 29161775
[TBL] [Abstract][Full Text] [Related]
19. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes.
Sad S; Chauhan VS; Arunan K; Raghupathy R
Vaccine; 1993; 11(11):1145-50. PubMed ID: 7504380
[TBL] [Abstract][Full Text] [Related]
20. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.
Simms MS; Scholfield DP; Jacobs E; Michaeli D; Broome P; Humphreys JE; Bishop MC
Br J Cancer; 2000 Aug; 83(4):443-6. PubMed ID: 10945488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
